Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 2/2018

01-04-2018 | Images

8p11 Stem Cell Leukemia/Lymphoma Syndrome without Myeloproliferation: A Rare Clinical Entity

Authors: Ahmad Monabati, Akbar Safaei, Moeinadin Safavi

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 2/2018

Login to get access

Excerpt

Patient was a 13 year old boy presenting with bilateral large neck lymphadenopathy. Imaging workup showed no mediastinal widening or abdominal organomegaly (spleen largest diameter was 10 cm). Complete blood count was as the following: white blood cell = 6800/µL (neutrophil = 46%, lymphocyte = 34%, Monocyte = 16%, Eosinophil = 4%), red blood cell = 4.420000/µL, hemoglobin = 13.3 gr/dL, hematocrit = 38%, platelet = 332,000/µL. Although bone marrow aspiration was normocellular, synchronized bone marrow culture revealed t(8;13) (p11;q12) (Fig. 1a). Cervical lymph node biopsy showed infiltration of small to medium lymphoid blasts with dusty chromatin extending to perinodal fat (Fig. 1B). Immunohistochemistry exhibited positive reaction for CD3, tdt and Ki67 which was compatible with T cell lymphoblastic lymphoma. Final diagnosis was 8p11 stem cell leukemia/lymphoma syndrome.
Literature
1.
go back to reference Jackson CC, Medeiros LJ, Miranda RN (2010) 8p11 myeloproliferative syndrome: a review. Human Pathol 41:461–476CrossRef Jackson CC, Medeiros LJ, Miranda RN (2010) 8p11 myeloproliferative syndrome: a review. Human Pathol 41:461–476CrossRef
2.
go back to reference Kuskonmaz B, Kafalı C, Akcoren Z, Karabulut HG, Akalin İ, Tuncer MA (2008) The 8p11 myeloproliferative syndrome in a 3-year-old child. Leuk Res 32:198–199CrossRefPubMed Kuskonmaz B, Kafalı C, Akcoren Z, Karabulut HG, Akalin İ, Tuncer MA (2008) The 8p11 myeloproliferative syndrome in a 3-year-old child. Leuk Res 32:198–199CrossRefPubMed
Metadata
Title
8p11 Stem Cell Leukemia/Lymphoma Syndrome without Myeloproliferation: A Rare Clinical Entity
Authors
Ahmad Monabati
Akbar Safaei
Moeinadin Safavi
Publication date
01-04-2018
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 2/2018
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-017-0884-y

Other articles of this Issue 2/2018

Indian Journal of Hematology and Blood Transfusion 2/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine